114 related articles for article (PubMed ID: 23865351)
1. Increased circulating levels of CXC chemokines is correlated with duration and complications of the disease in type-1 diabetes: a study on Iranian diabetic patients.
Hakimizadeh E; Shamsizadeh A; Nazari M; Arababadi MK; Rezaeian M; Vazirinejad R; Jamali Z; Poor NM; Khorramdelazad H; Darakhshan S; Hassanshahi G
Clin Lab; 2013; 59(5-6):531-7. PubMed ID: 23865351
[TBL] [Abstract][Full Text] [Related]
2. Expression of CC chemokines CCL2, CCL5, and CCL11 is associated with duration of disease and complications in type-1 diabetes: a study on Iranian diabetic patients.
Jamali Z; Nazari M; Khoramdelazad H; Hakimizadeh E; Mahmoodi M; Karimabad MN; Hassanshahi G; Rezaeian M; Balaei P; Darakhshan S; Poor NM
Clin Lab; 2013; 59(9-10):993-1001. PubMed ID: 24273921
[TBL] [Abstract][Full Text] [Related]
3. Overproduction of CXC chemokines CXCL1, CXCL9, CXCL10 and CXCL12 in β-thalassemia major or patients.
Najmaddini H; Hassanshahi G; Ostadebrahimi H; Barkhordari H; Mashayekhi H; Nazari M; Moogooei M; Arababadi YS; Peighambari F; Karimabad MN
Ann Saudi Med; 2014; 34(2):122-7. PubMed ID: 24894780
[TBL] [Abstract][Full Text] [Related]
4. Differential expression of CXCL1, CXCL9, CXCL10 and CXCL12 chemokines in alopecia areata.
Zainodini N; Hassanshahi G; Arababadi MK; Khorramdelazad H; Mirzaei A
Iran J Immunol; 2013 Mar; 10(1):40-6. PubMed ID: 23502337
[TBL] [Abstract][Full Text] [Related]
5. CXC chemokines CXCL1, CXCL9, CXCL10 and CXCL12 are variably expressed in patients with sickle cell disease and carriers: are they predictive tools for disease complications?
Ostadebrahimi H; Jamali Z; Nazari M; Bahri M; Farahmandnia Z; Khandany BK; Taheri M; Khorramdelazad H; Hakimizadeh E; Zaker F; Rezaeian M; Hassanshahi G
Clin Lab; 2014; 60(1):99-104. PubMed ID: 24600982
[TBL] [Abstract][Full Text] [Related]
6. Plasma levels of CXCL1 (GRO-alpha) and CXCL10 (IP-10) are elevated in type 2 diabetic patients: evidence for the involvement of inflammation and angiogenesis/angiostasis in this disease state.
Sajadi SM; Khoramdelazad H; Hassanshahi G; Rafatpanah H; Hosseini J; Mahmoodi M; Arababadi MK; Derakhshan R; Hasheminasabzavareh R; Hosseini-Zijoud SM; Ahmadi Z
Clin Lab; 2013; 59(1-2):133-7. PubMed ID: 23505918
[TBL] [Abstract][Full Text] [Related]
7. CXCL9/CXCL10 angiostasis CXC-chemokines in parallel with the CXCL12 as an angiogenesis CXC-chemokine are variously expressed in pre-eclamptic-women and their neonates.
Darakhshan S; Hassanshahi G; Mofidifar Z; Soltani B; Karimabad MN
Pregnancy Hypertens; 2019 Jul; 17():36-42. PubMed ID: 31487653
[TBL] [Abstract][Full Text] [Related]
8. The proinflammatory CXC-chemokines GRO-alpha/CXCL1 and MIG/CXCL9 are concomitantly expressed in ulcerative colitis and decrease during treatment with topical corticosteroids.
Egesten A; Eliasson M; Olin AI; Erjefält JS; Bjartell A; Sangfelt P; Carlson M
Int J Colorectal Dis; 2007 Dec; 22(12):1421-7. PubMed ID: 17703315
[TBL] [Abstract][Full Text] [Related]
9. Serum concentration of angiogenic (CXCL1, CXCL12) and angiostasis (CXCL9, CXCL10) CXC chemokines are differentially altered in normal and gestational diabetes mellitus associated pregnancies.
Darakhshan S; Fatehi A; Hassanshahi G; Mahmoodi S; Hashemi MS; Karimabad MN
J Diabetes Metab Disord; 2019 Dec; 18(2):371-378. PubMed ID: 31890662
[TBL] [Abstract][Full Text] [Related]
10. Chemokine profiling in serum from patients with ovarian cancer reveals candidate biomarkers for recurrence and immune infiltration.
Mlynska A; Salciuniene G; Zilionyte K; Garberyte S; Strioga M; Intaite B; Barakauskiene A; Lazzari G; Dobrovolskiene N; Krasko JA; Pasukoniene V
Oncol Rep; 2019 Feb; 41(2):1238-1252. PubMed ID: 30483809
[TBL] [Abstract][Full Text] [Related]
11. Serum CXCL1 concentrations are elevated in type 1 diabetes mellitus, possibly reflecting activity of anti-islet autoimmune activity.
Takahashi K; Ohara M; Sasai T; Homma H; Nagasawa K; Takahashi T; Yamashina M; Ishii M; Fujiwara F; Kajiwara T; Taneichi H; Takebe N; Satoh J
Diabetes Metab Res Rev; 2011 Nov; 27(8):830-3. PubMed ID: 22069268
[TBL] [Abstract][Full Text] [Related]
12. Serum chemokine receptor CXCR3 ligands are associated with progression, organ dysfunction and complications of chronic liver diseases.
Tacke F; Zimmermann HW; Berres ML; Trautwein C; Wasmuth HE
Liver Int; 2011 Jul; 31(6):840-9. PubMed ID: 21645215
[TBL] [Abstract][Full Text] [Related]
13. Seminal Levels of Pro-inflammatory (CXCL1, CXCL9, CXCL10) and Homeostatic (CXCL12) Chemokines in Men With Asymptomatic Chlamydia trachomatis Infection.
Hakimi H; Zainodini N; Khorramdelazad H; Kazemi Arababadi M; Hassanshahi G
Jundishapur J Microbiol; 2014 Dec; 7(12):e11152. PubMed ID: 25741424
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of circulating concentrations of CXCL1 (Gro-α), CXCL10 (IP-10) and CXCL12 (SDF-1) in ALL patients prior and post bone marrow transplantation.
Khandany BK; Hassanshahi G; Khorramdelazad H; Balali Z; Shamsizadeh A; Arababadi MK; Ostadebrahimi H; Fatehi A; Rezazadeh M; Ahmadi Z; Karimabad MN
Pathol Res Pract; 2012 Oct; 208(10):615-9. PubMed ID: 22975476
[TBL] [Abstract][Full Text] [Related]
15. Increased urinary levels of CXCL5, CXCL8 and CXCL9 in patients with Type 2 diabetic nephropathy.
Higurashi M; Ohya Y; Joh K; Muraguchi M; Nishimura M; Terawaki H; Yagui K; Hashimoto N; Saito Y; Yamada K
J Diabetes Complications; 2009; 23(3):178-84. PubMed ID: 18413205
[TBL] [Abstract][Full Text] [Related]
16. The role of some chemokines from the CXC subfamily in a mouse model of diabetic neuropathy.
Zychowska M; Rojewska E; Pilat D; Mika J
J Diabetes Res; 2015; 2015():750182. PubMed ID: 25789329
[TBL] [Abstract][Full Text] [Related]
17. Levels of serum chemokines discriminate clinical myelopathy associated with human T lymphotropic virus type 1 (HTLV-1)/tropical spastic paraparesis (HAM/TSP) disease from HTLV-1 carrier state.
Guerreiro JB; Santos SB; Morgan DJ; Porto AF; Muniz AL; Ho JL; Teixeira AL; Teixeira MM; Carvalho EM
Clin Exp Immunol; 2006 Aug; 145(2):296-301. PubMed ID: 16879249
[TBL] [Abstract][Full Text] [Related]
18. Cytokines and T regulatory cells in the pathogenesis of type 1 diabetes.
Kikodze N; Pantsulaia I; Rekhviashvili Kh; Iobadze M; Dzhakhutashvili N; Pantsulaia N; Kukuladze N; Bikashvili N; Metreveli D; Chikovani T
Georgian Med News; 2013 Sep; (222):29-35. PubMed ID: 24099812
[TBL] [Abstract][Full Text] [Related]
19. Monitoring serum levels ELR+ CXC chemokines and the relationship between microvessel density and angiogenic growth factors in multiple myeloma.
Pappa CA; Tsirakis G; Kanellou P; Kaparou M; Stratinaki M; Xekalou A; Alegakis A; Boula A; Stathopoulos EN; Alexandrakis MG
Cytokine; 2011 Dec; 56(3):616-20. PubMed ID: 21940178
[TBL] [Abstract][Full Text] [Related]
20. Pleiotropic effects of CXC chemokines in gastric carcinoma: differences in CXCL8 and CXCL1 expression between diffuse and intestinal types of gastric carcinoma.
Eck M; Schmausser B; Scheller K; Brändlein S; Müller-Hermelink HK
Clin Exp Immunol; 2003 Dec; 134(3):508-15. PubMed ID: 14632759
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
